Ligand validation:5P9V

CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID

CXS is a Ligand Of Interest in 5P9V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5P9V_CXS_A_307	25%	21%	0.209	0.845	2	1.31	2	2	0	0	100%	1
5P9V_CXS_A_308	1%	25%	0.349	0.411	1.94	1.15	4	2	0	0	100%	1
5K0B_CXS_H_302	86%	22%	0.121	0.991	1.02	2.19	2	5	0	0	100%	1
3HVH_CXS_A_3	73%	24%	0.101	0.928	1.69	1.43	2	3	0	0	100%	1
5PA0_CXS_A_304	48%	31%	0.144	0.888	0.94	1.78	1	5	1	0	100%	1
9AUQ_CXS_B_202	100%	16%	0.03	0.993	2.34	1.36	2	2	0	0	100%	1
6GAL_CXS_M_604	100%	35%	0.043	0.993	1.04	1.52	1	2	0	0	100%	1
2QGQ_CXS_F_501	99%	54%	0.054	0.987	0.76	1.03	-	1	0	0	100%	1
3OBL_CXS_B_134	98%	19%	0.058	0.981	2.3	1.18	2	3	0	0	100%	1
1RZL_CXS_A_201	97%	29%	0.067	0.984	1.4	1.44	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.